Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are one of the most maturely developed TPD techniques. With this critique, we center on both preclinical experiments and medical trials to provide an extensive summary of the protection and scientific usefulness of PROTACs and MGDs in hematologic malignancies in the last https://nicholasy863oty7.blogvivi.com/profile